ECTRIMS

Patricia Coyle: ECTRIMS Presents Positive Results for Patients

September 19, 2016

Video

As the annual ECTRIMS conference in London wound down there was definitely a sense of optimism that there would be more good news to come before the group meets next October in Paris.

Patricia Coyle from Stony Brook Medicine: Teri-PRO Trial shows Continued Benefits of Aubagio

September 19, 2016

Video

When a medication is approved the data from that time can sometimes be of more value than the trials leading up to the approval. For Aubagio there was a recent study done looking at patient satisfaction and other issues following the approval.

Severe Vitamin D Deficiency and Smoking Spike the Risk of MS Disability

September 17, 2016

Article

One of the late breaking studies at ECTRIMS 2016 looked at how 25OH vitamin D (25OHVitD) and smoking influences disability in patients with MS.

Siponimod Significantly Reduces Disability Progression Risk in SPMS

September 17, 2016

Article

Researchers have evaluated siponimod's efficacy in treating secondary progressive multiple sclerosis (SPMS) in a phase 3 trial.

Chase Spurlock from Vanderbilt University: New Blood Test Could Catch Multiple Sclerosis Sooner

September 17, 2016

Video

At the moment the best way to get a diagnosis of multiple sclerosis is through a brain scan. A team in Tennessee is working to improve that with a blood test that could find the condition sooner allowing for treatment to begin faster.

Aaron Boster: Building Excitement Out of ECTRIMS

September 17, 2016

Video

As the leading minds in the field of multiple sclerosis came together in London for the annual ECTRIMS conference the end of the conference brought a considerable amount of excitement in everything from the relapsing form to progressive forms.

Aaron Boster from OhioHealth: Extended Data On Lemtrada Shows More Good News

September 17, 2016

Video

As more and more treatments are approved for patients with multiple sclerosis questions are being answered about their effectiveness long past their approval dates. This is true for many of the medications including lemtrada.

Fampridine Gets a Thumbs Up for Improving MS Walking Disability

September 17, 2016

Article

Previous research has shown that prolonged-release fampridine (PR-FAM) can help walking ability in patients with multiple sclerosis (MS), however, it’s unclear whether those findings are clinically significant.

Younger Multiple Sclerosis Age Onset Could Mean Accelerated NAWM Changes

September 16, 2016

Article

Are patients worse off if they are diagnosed with multiple sclerosis at a younger age? That’s what Italian researchers aimed to make more clear at ECTRIMS 2016.

Igor Koralnik: Finding the Right Treatment for PML

September 16, 2016

Video

While neurologists may be able to successfully diagnose progressive multifocal leukoencephalopathy it may take a more specialized health care professional to effectively treat the condition.

x